Company / Current Assets
Atea Pharmaceuticals, Inc. Current Assets History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$660.9M
FY2022
5-year range
$660.9M / $863.5M
FY2020-FY2022
Trend
-14.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $863M to $661M over the past 2 years.
Based on SEC 10-K filings.
$661M in FY2022.
Declined from $863M to $661M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets decreased 14.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $660.9M | -14.4% |
| FY2021 | $772.4M | -10.5% |
| FY2020 | $863.5M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026